FDA approves 23 new drugs in first half, overcoming staff-cut concerns

July 6, 2026 01:27 PM EDT PharmaFDA+ FDA ap­provals out­run staff cuts: 23 nov­el drugs mark the best first half in three years Zachary Brennan Senior Editor There’s an an­swer emerg­ing on the multi­bil­lion-dol­lar ques­tion of whether the Trump ad­min­is­tra­tion’s gut­ting of FDA staff in April 2025 would slow down drug ap­provals: … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER